Literature DB >> 11331265

Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report.

A M Gotto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11331265     DOI： 10.1161/01.cir.103.17.2213

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  24 in total

1.  Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in São Paulo compared to Natives and Japanese-Brazilians in Japan.

Authors:  Andiara Schwingel; Yoshio Nakata; Lucy S Ito; Wojtek J Chodzko-Zajko; Ryosuke Shigematsu; Christopher T Erb; Simone M Souza; Sueli M Oba-Shinjo; Tomoaki Matsuo; Suely K N Marie; Kiyoji Tanaka
Journal:  Eur J Epidemiol       Date:  2007-01-17       Impact factor: 8.082

2.  Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia.

Authors:  Anandan Palani; Ashwin U Rao; Xiao Chen; Xianhai Huang; Jing Su; Haiqun Tang; Ying Huang; Jun Qin; Dong Xiao; Sylvia Degrado; Michael Sofolarides; Xiaohong Zhu; Zhidan Liu; Brian McKittrick; Wei Zhou; Robert Aslanian; William J Greenlee; Mary Senior; Boonlert Cheewatrakoolpong; Hongtao Zhang; Constance Farley; John Cook; Stan Kurowski; Qiu Li; Margaret van Heek; Gangfeng Wang; Yunsheng Hsieh; Fangbiao Li; Scott Greenfeder; Madhu Chintala
Journal:  ACS Med Chem Lett       Date:  2011-11-24       Impact factor: 4.345

Review 3.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

4.  Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemia.

Authors:  Jun Qin; Ashwin Rao; Xiao Chen; Xiaohong Zhu; Zhidan Liu; Xianhai Huang; Sylvia Degrado; Ying Huang; Dong Xiao; Robert Aslanian; Boonlert Cheewatrakoolpong; Hongtao Zhang; Scott Greenfeder; Constance Farley; John Cook; Stan Kurowski; Qiu Li; Margaret van Heek; Madhu Chintala; Ganfeng Wang; Yunsheng Hsieh; Fangbiao Li; Anandan Palani
Journal:  ACS Med Chem Lett       Date:  2010-12-08       Impact factor: 4.345

5.  Improved endothelial dysfunction by Cynanchum wilfordii in apolipoprotein E(-/-) mice fed a high fat/cholesterol diet.

Authors:  Deok Ho Choi; Yun Jung Lee; Hyun Cheol Oh; Ying Lan Cui; Jin Sook Kim; Dae Gill Kang; Ho Sub Lee
Journal:  J Med Food       Date:  2011-11-14       Impact factor: 2.786

Review 6.  New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterol.

Authors:  M E Brousseau; E J Schaefer
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 7.  The hypertension peril: lessons from CETP inhibitors.

Authors:  Matthias Hermann; Frank T Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

Review 8.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

9.  Atorvastatin versus Bezafibrate in Mixed Hyperlipidaemia : Randomised Clinical Trial of Efficacy and Safety (the ATOMIX Study).

Authors:  Emilio Ros; Josefina Oliván; José M Mostaza; Miquel Vilardell; Xavier Pintó; Fernando Civeira; A Hernández; Pedro Marqués da Silva; A Rodriguez-Botaro; Daniel Zambón; Joan Lima; José A Gómez-Gerique; Cristina Díaz; Rosa Arístegui; José M Sol; Gonzalo Hernández
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms.

Authors:  Genovefa D Kolovou; Katherine K Anagnostopoulou; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.